Fibromyalgia Drugs Tested for Value

• by Kathryn Wighton

• March 23, 2026

RA Outcomes Improved in KURAMA Cohort

Ten-year observational data showed lower disease activity and functional disability coinciding with broader use of biologic and targeted synthetic therapies.

• by Andrea Surnit

• May 22, 2026

• 4 min

JAK Monotherapy Shows Efficacy in RA Review

A systematic review found Janus kinase inhibitor monotherapy improved outcomes vs methotrexate or placebo, but direct comparisons with combination therapy were limited.

• by Andrea Surnit

• May 22, 2026

• 4 min

Is histamine intolerance a treatable subtype of fibromyalgia? evidence and clinical implications—narrative review

• by João Protásio Netto, José Fábio Lana, Alexandre Parma, Fábio Ramos Costa, Rubens Martins de Andrade, Mariana Garcia Martins Castro, Claudia Tambelli

• April 30, 2026